跳至主要内容
临床试验/NCT05570435
NCT05570435已完成不适用

Evaluate Efficacy of Milk Product Supplemented With Bioactives in Lowering Post Meal Glucose Response: an Acute Study in Chinese Population

Société des Produits Nestlé (SPN)1 个研究点 分布在 1 个国家目标入组 31 人开始时间: 2022年11月16日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
31
试验地点
1
主要终点
3h-iAUC of PPGR

研究概览

简要总结

This is a monocentric, randomized controlled, open-label, 2x2 cross-over study. The main objective of the study is to Evaluate the efficacy of Nestle YIYANG TangLv milk powder in lowering the Post Prandial Glucose Response (PPGR) of a high carbohydrate meal when consumed with the meal.

详细描述

This is an acute, monocentric, open label, randomized, 2-arm, cross-over, clinical trial in 30 subjects of Chinese Han ethnicity. Subjects will receive the two different interventions in a randomized order. This study will assess the efficacy of the investigational product after a single consumption. Day before (V1 and V3) the intervention visits (V2 and V4) the subjects will be admitted at the investigational site for an overnight stay where they will consume a standardized dinner. V2 and V3 will be followed by a wash-out period of 3 days. The two arms are:

Arm 1: skimmed milk (control) Arm 2: Nestle YIYANG TangLv milk powder

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
None

入排标准

年龄范围
45 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Willing and able to sign written informed consent prior to trial entry
  • Deemed able to comply with study protocol for 2-3 weeks
  • Male or female aged 45-75 years (inclusive 45 and 75)
  • HbA1c test results < 6.5% at Visit 1 (Admission 1)
  • Waist circumference ≤90 cm in males and ≤ 85 cm in females
  • Chinese Han ethnic group
  • BMI >18.5 and <28 kg/m2

排除标准

  • Pre-existing chronic medical or psychiatric conditions, as diagnosed by the treating physician (psychiatric illness, asthma or chronic lung disease requiring long term medications or oxygen, diabetes mellitus, chronic infective disease, including tuberculosis, hepatitis B and C, and HIV)
  • Significant medical or surgical event in the past 3 months potentially interfering with study procedures and assessments
  • Known food allergy in particular cow's milk protein allergy (CMPA), lactose and /or soy intolerance or known hypersensitivity/intolerance to any other ingredients in the study product
  • Known substance abuse or alcohol user exceeds following intake, alcohol intake > 2 servings per day. A serving is 0.4 dl of strong alcohols, 1 dl of red or white wine, or 3 dl of beer
  • Consumption of tobacco products, smoking or chewing tobacco
  • History of significant organ dysfunction or disease
  • Subjects with refractory hypertension, and patients with hypertension who are taking antihypertensive drugs (beta-blockers, thiazide diuretics, etc.) that may affect blood glucose metabolism
  • Females currently on hormonal therapy including post-menopausal hormone replacement therapy (PRT) or have been on PRT treatment in the past two months before study participation
  • Known autoimmune and/or genetic disease
  • Known chronic diarrhea or gastrointestinal discomfort
  • Known endocrine and metabolic diseases under drug treatment (e.g., pituitary tumors, thyrotoxicosis due to various causes, Cushing's syndrome etc.)
  • Subjects on systemic corticosteroids, glucocorticoids, or cyclosporine A
  • Recent blood donation (<8 weeks)
  • Pregnant or lactating women

研究组 & 干预措施

YIYANG TangLv milk powder

Experimental

30g of milk powder (Nestle YIYANG TangLv milk powder) containing 789 mg Reducose® extract, standardized to contain 1% 1-deoxynojirimycin (1-DNJ), 10% of an oil mix and 8% of soluble fiber reconstituted with 180 ml of warm water.

干预措施: Blood collection (Biological)

skimmed milk

Active Comparator

25g of commercially available skimmed milk powder reconstituted with 180 ml of warm water.

干预措施: Blood collection (Biological)

结局指标

主要结局

3h-iAUC of PPGR

时间窗: 3 hours

Incremental area under the curve (3h-iAUC0-3h) of the post-prandial plasma glucose concentration (PPGR)

次要结局

  • Cmax of PPGR(3 hours)
  • iAUC of PPIR(1 hour, 2 hours)
  • iCmax of PPIR(3 hours)
  • iAUC of PPGR(1hour, 2 hours)
  • Tmax of PPGR(3 hours)
  • Tmax of PPIR(3 hours)
  • iCmax of PPGR(3 hours)
  • Cmax of PPIR(3 hours)

研究者

发起方
Société des Produits Nestlé (SPN)
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验